Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Sa, Marsters"'
Publikováno v:
Europe PubMed Central
It has been previously reported that inhibition of human erythroid colony-forming units (CFU-E) in vitro by interleukin-1 (IL-1) is an indirect effect, occurring through the production of interferon gamma (IFN gamma). IFN gamma, in turn, inhibits CFU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b2be35e3ac2e173f9a7733b4da378e
https://pubmed.ncbi.nlm.nih.gov/8111063
https://pubmed.ncbi.nlm.nih.gov/8111063
Autor:
Rodvold JJ; Department of Research Oncology, Genentech, Inc., South San Francisco, California., Grimmer M; Department of Computational Science, Genentech, Inc., South San Francisco, California., Ruiz K; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Marsters SA; Department of Research Oncology, Genentech, Inc., South San Francisco, California., Oikonomidi I; Department of Research Oncology, Genentech, Inc., South San Francisco, California., Tan-Aristy E; Department of Research Oncology, Genentech, Inc., South San Francisco, California., Pham VC; Department of Microchemistry, Proteomics, and Lipidomics, Genentech, Inc., South San Francisco, California., Sarkar T; Department of General, Visceral, Thoracic, and Transplantation Surgery, University Hospital Giessen, Giessen, Germany., Harnoss JM; Department of General, Visceral, Thoracic, and Transplantation Surgery, University Hospital Giessen, Giessen, Germany., Shatz-Binder W; Department of Pharmaceutical Development, Genentech, Inc., South San Francisco, California., Modrusan ZD; Department of Microchemistry, Proteomics, and Lipidomics, Genentech, Inc., South San Francisco, California., Wu TD; Department of Computational Science, Genentech, Inc., South San Francisco, California., Lill JR; Department of Microchemistry, Proteomics, and Lipidomics, Genentech, Inc., South San Francisco, California., Villemure E; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, California., Rudolph J; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, California., de Sousa E Melo F; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Ashkenazi A; Department of Research Oncology, Genentech, Inc., South San Francisco, California.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Oct 01; Vol. 4 (10), pp. 2734-2755.
Autor:
Harnoss JM; Cancer Immunology, Genentech, Inc., South San Francisco, California., Le Thomas A; Cancer Immunology, Genentech, Inc., South San Francisco, California., Reichelt M; Pathology, Genentech, Inc., South San Francisco, California., Guttman O; Cancer Immunology, Genentech, Inc., South San Francisco, California., Wu TD; Bioinformatics, Genentech, Inc., South San Francisco, California., Marsters SA; Cancer Immunology, Genentech, Inc., South San Francisco, California., Shemorry A; Cancer Immunology, Genentech, Inc., South San Francisco, California., Lawrence DA; Cancer Immunology, Genentech, Inc., South San Francisco, California., Kan D; Translational Oncology, Genentech, Inc., South San Francisco, California., Segal E; Translational Oncology, Genentech, Inc., South San Francisco, California., Merchant M; Translational Oncology, Genentech, Inc., South San Francisco, California., Totpal K; Translational Oncology, Genentech, Inc., South San Francisco, California., Crocker LM; Translational Oncology, Genentech, Inc., South San Francisco, California., Mesh K; Pathology, Genentech, Inc., South San Francisco, California., Dohse M; Pathology, Genentech, Inc., South San Francisco, California., Solon M; Pathology, Genentech, Inc., South San Francisco, California., Modrusan Z; Molecular Biology, Genentech, Inc., South San Francisco, California., Rudolph J; Discovery Chemistry, Genentech, Inc., South San Francisco, California., Koeppen H; Pathology, Genentech, Inc., South San Francisco, California., Walter P; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California.; Howard Hughes Medical Institute, University of California San Francisco, San Francisco, California., Ashkenazi A; Cancer Immunology, Genentech, Inc., South San Francisco, California. ashkenazi.avi@gene.com.
Publikováno v:
Cancer research [Cancer Res] 2020 Jun 01; Vol. 80 (11), pp. 2368-2379. Date of Electronic Publication: 2020 Apr 07.
Autor:
Lam M; Department of Biochemistry and Biophysics, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States., Marsters SA; Cancer Immunology, Genentech, Inc, San Francisco, United States., Ashkenazi A; Cancer Immunology, Genentech, Inc, San Francisco, United States., Walter P; Department of Biochemistry and Biophysics, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States.; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States.
Publikováno v:
ELife [Elife] 2020 Jan 06; Vol. 9. Date of Electronic Publication: 2020 Jan 06.
Autor:
Shemorry A; Cancer Immunology, Genentech, South San Francisco, United States., Harnoss JM; Cancer Immunology, Genentech, South San Francisco, United States., Guttman O; Cancer Immunology, Genentech, South San Francisco, United States., Marsters SA; Cancer Immunology, Genentech, South San Francisco, United States., Kőműves LG; Department of Pathology, Genentech, South San Francisco, United States., Lawrence DA; Cancer Immunology, Genentech, South San Francisco, United States., Ashkenazi A; Cancer Immunology, Genentech, South San Francisco, United States.
Publikováno v:
ELife [Elife] 2019 Aug 27; Vol. 8. Date of Electronic Publication: 2019 Aug 27.
Autor:
Harnoss JM; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Le Thomas A; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Shemorry A; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Marsters SA; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Lawrence DA; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Lu M; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Chen YA; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Qing J; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080., Totpal K; Translational Oncology, Genentech, Inc., South San Francisco, CA 94080., Kan D; Translational Oncology, Genentech, Inc., South San Francisco, CA 94080., Segal E; Translational Oncology, Genentech, Inc., South San Francisco, CA 94080., Merchant M; Translational Oncology, Genentech, Inc., South San Francisco, CA 94080., Reichelt M; Pathology, Genentech, Inc., South San Francisco, CA 94080., Ackerly Wallweber H; Structural Biology, Genentech, Inc., South San Francisco, CA 94080., Wang W; Structural Biology, Genentech, Inc., South San Francisco, CA 94080., Clark K; Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA 94080., Kaufman S; Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA 94080., Beresini MH; Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA 94080., Laing ST; Pathology, Genentech, Inc., South San Francisco, CA 94080., Sandoval W; Microchemistry, Proteomics and Lipidomics, Genentech, Inc., South San Francisco, CA 94080., Lorenzo M; Protein Chemistry, Genentech, Inc., South San Francisco, CA 94080., Wu J; Protein Chemistry, Genentech, Inc., South San Francisco, CA 94080., Ly J; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080., De Bruyn T; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080., Heidersbach A; Molecular Biology, Genentech, Inc., South San Francisco, CA 94080., Haley B; Molecular Biology, Genentech, Inc., South San Francisco, CA 94080., Gogineni A; Biomolecular Imaging, Genentech, Inc., South San Francisco, CA 94080., Weimer RM; Biomolecular Imaging, Genentech, Inc., South San Francisco, CA 94080., Lee D; Safety Assessment, Genentech, Inc., South San Francisco, CA 94080., Braun MG; Discovery Chemistry, Genentech, Inc., South San Francisco, CA 94080., Rudolph J; Discovery Chemistry, Genentech, Inc., South San Francisco, CA 94080., VanWyngarden MJ; Division of Hematology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO 80045., Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO 80045., Gomez-Bougie P; Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, INSERM, CNRS, Université d'Angers, Université de Nantes, BP 70721 Nantes, France.; Service d'Hématologie Clinique, Unité d'Investigation Clinique, Centre Hospitalier Universitaire, BP 70721 Nantes, France., Amiot M; Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, INSERM, CNRS, Université d'Angers, Université de Nantes, BP 70721 Nantes, France.; Service d'Hématologie Clinique, Unité d'Investigation Clinique, Centre Hospitalier Universitaire, BP 70721 Nantes, France., Acosta-Alvear D; Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143.; Howard Hughes Medical Institute, University of California, San Francisco, CA 94143., Walter P; Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143.; Howard Hughes Medical Institute, University of California, San Francisco, CA 94143., Ashkenazi A; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080; aa@gene.com.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Aug 13; Vol. 116 (33), pp. 16420-16429. Date of Electronic Publication: 2019 Aug 01.
Autor:
Chang TK; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Lawrence DA; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Lu M; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Tan J; Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080, USA., Harnoss JM; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Marsters SA; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA., Liu P; Microchemistry Proteomics and Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Sandoval W; Microchemistry Proteomics and Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Martin SE; Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080, USA., Ashkenazi A; Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: aa@gene.com.
Publikováno v:
Molecular cell [Mol Cell] 2018 Aug 16; Vol. 71 (4), pp. 629-636.e5.
Autor:
Zuch de Zafra CL; Safety Assessment, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Ashkenazi A; Department of Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Darbonne WC; Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Cheu M; BioAnalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Totpal K; Department of Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Ortega S; Safety Assessment, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Flores H; Late Stage Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Walker MD; Charles River Laboratories Inc. (formerly Sierra Biomedical), 587 Dunn Circle, Sparks, NV 89431, USA., Kabakoff B; Early Stage Pharmaceutical Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Lum BL; Clinical Pharmacology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Mounho-Zamora BJ; Toxicology Department, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Marsters SA; Department of Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Dybdal NO; Safety Assessment, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Publikováno v:
Cell death & disease [Cell Death Dis] 2016 Aug 11; Vol. 7 (8), pp. e2338. Date of Electronic Publication: 2016 Aug 11.
Autor:
Petersen SL; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Chen TT; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Lawrence DA; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Marsters SA; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Gonzalvez F; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Ashkenazi A; Cancer Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2015 Nov; Vol. 22 (11), pp. 1846-57. Date of Electronic Publication: 2015 Apr 17.
Autor:
Li B; Department of Protein Engineering, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Russell SJ, Compaan DM, Totpal K, Marsters SA, Ashkenazi A, Cochran AG, Hymowitz SG, Sidhu SS
Publikováno v:
Journal of molecular biology [J Mol Biol] 2006 Aug 18; Vol. 361 (3), pp. 522-36. Date of Electronic Publication: 2006 Jul 07.